Vascular factors are associated with the severity of the neuropsychiatric symptoms in Alzheimer's disease

References

• Karttunen K, Karppi P, Hiltunen A, Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. Int J Geriatr Psychiatry 2011;26: 473–82.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Rosenheck R, Lyketsos CG, Schneider LS. Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 2010;18:917–27.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Meguro M, Meguro K. Sleep disturbance is associated with decreased daily activity and impaired nocturnal reduction of blood pressure in dementia patients. Arch Gerontol Geriatr 2011;53:323–7.
   Google Scholar
• Tekin S, Fairbanks LA, O'Connor S, Activities of daily living in Alzheimer's disease: neuropsychiatric, cognitive, and medical illness influences. Am J Geriatr Psychiatry 2001;9:81–6.
   PubMed Web of Science ®Google Scholar
• Burns A, Lewis G, Jacoby R, Levy R. Factors affecting survival in Alzheimer's disease. Psychol Med 1991;21:363–70.
   PubMed Web of Science ®Google Scholar
• Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009;5:649–58.
   PubMed Web of Science ®Google Scholar
• Serra L, Perri R, Cercignani M, Are the behavioral symptoms of Alzheimer's disease directly associated with neurodegeneration? J Alzheimer's Dis 2010;21:627–39.
   PubMed Web of Science ®Google Scholar
• Le Ber I, Guedj E, Gabelle A, Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain: a journal of neurology 2006;129:3051–65.
   PubMed Web of Science ®Google Scholar
• Levy-Cooperman N, Burhan AM, Rafi-Tari S, Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease. J Psychiatry Neurosci 2008;33:218–26.
   PubMed Web of Science ®Google Scholar
• Gilley DW, Wilson RS, Bienias JL, Predictors of depressive symptoms in persons with Alzheimer's disease. J Gerontol B: Psychological Sciences and Social Sciences 2004;59: P75–83.
   Google Scholar
• Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006;77:8–11.
   PubMed Web of Science ®Google Scholar
• Bassiony MM, Steinberg MS, Warren A, Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 2000;15:99–107.
   Google Scholar
• Gabryelewicz T, Religa D, Styczynska M, Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement Geriatr Cogn Disord 2002;14:208–12.
   Google Scholar
• Craig D, Hart DJ, McCool K, Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:1327–30.
   PubMed Web of Science ®Google Scholar
• van der Flier WM, Staekenborg S, Pijnenburg YA, Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 2007;23:42–6.
   PubMed Web of Science ®Google Scholar
• Treiber KA, Lyketsos CG, Corcoran C, Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr 2008;20:538–53.
   PubMed Web of Science ®Google Scholar
• Jonsson M, Edman A, Lind K, Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia. Int J Geriatr Psychiatry 2010;25: 588–95.
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44.
   PubMed Web of Science ®Google Scholar
• Cummings JL, Mega M, Gray K, The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–14.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–6.
   PubMed Web of Science ®Google Scholar
• Scheltens P, Barkhof F, Leys D, A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7–12.
   PubMed Web of Science ®Google Scholar
• Shim YS, Youn YC, Na DL, Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease. Eur Neurol 2011;66:75–82.
   Google Scholar
• Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412–4.
   PubMed Web of Science ®Google Scholar
• Yao H, Takashima Y, Mori T, Hypertension and white matter lesions are independently associated with apathetic behavior in healthy elderly subjects: the Sefuri brain MRI study. Hypertens Res 2009;32:586–90.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Fedoroff JP, Price TR, Apathy following cerebrovascular lesions. Stroke 1993;24:1625–30.
   PubMed Web of Science ®Google Scholar
• Onoda K, Kuroda Y, Yamamoto Y, Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study. Cerebrovasc Dis 2011;31:6–11.
   PubMed Web of Science ®Google Scholar
• Hama S, Yamashita H, Shigenobu M, Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry 2007;22:1046–51.
   PubMed Web of Science ®Google Scholar
• David R, Koulibaly M, Benoit M, Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg 2008;110:19–24.
   Google Scholar
• Santos M, Gold G, Kovari E, Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke 2009;40:3557–62.
   PubMed Web of Science ®Google Scholar
• Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 2000;54:1805–10.
   PubMed Web of Science ®Google Scholar
• Yang C, DeVisser A, Martinez JA, Differential impact of diabetes and hypertension in the brain: adverse effects in white matter. Neurobiol Dis 2011;42:446–58.
   Google Scholar
• Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc 1996;44:1078–81.
   PubMed Web of Science ®Google Scholar
• Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:130–5.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Lopez O, Jones B, Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–83.
   PubMed Web of Science ®Google Scholar
• Feldman H, Scheltens P, Scarpini E, Behavioral symptoms in mild cognitive impairment. Neurology 2004;62:1199–201.
   PubMed Web of Science ®Google Scholar
• Hwang TJ, Masterman DL, Ortiz F, Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord 2004;18:17–21.
   PubMed Web of Science ®Google Scholar
• Choi SH, Na DL, Kwon HM, The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci 2000;15:609–15.
   PubMed Web of Science ®Google Scholar
• Robert PH, Verhey FR, Byrne EJ, Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry 2005;20:490–6.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Sheppard JM, Steinberg M, Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry 2001;16:1043–53.
   PubMed Web of Science ®Google Scholar
• Canevelli M, Adali N, Voisin T, Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory. Int J Geriatr Psychiatry 2013;28:795–803.
   PubMed Web of Science ®Google Scholar